Andrew has added some more to his excellent ongoing commentary about Sansrosa.
A recent blog post titled Alphagan P (0.15% brimonidine) and SansRosa, makes the suggestion that the interesting looking Sansrosa invention may have started life as eye drops for glaucoma.
Reading the side effects of `Alphagan P’ is pretty sobering, so if indeed the suggested link from the drops to Sansrosa is correct, the real discovery will be how to incorporate it into a treatment with a better safety profile.
Nice digging Andrew, I am looking forward to reading more.
